A shadow market for unapproved slimming drugs is propelled by social media fitness personalities and sellers on messaging platforms, according to recent findings.
Experimental Drug Acquiring Popularity Online
The experimental drug, which remains in clinical trials, is being promoted by social media influencers for its supposed weight-reducing properties. Viewers are urged to contact these profiles directly for supplier links, while also obtaining promotional offers.
Active Trade on Social Networks
Additionally, a flourishing trade exists on messaging services, where communities with thousands of participants share “before and after” images, injection guides and claims of rapid UK delivery. Vendors promote the drug there before redirecting customers to WhatsApp for purchases.
Understanding The Experimental Drug
Retatrutide is an experimental injectable created by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help patients lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.
Medical Professionals Express Worries
However, doctors and pharmacists have cautions that the distribution of what is still an unlicensed medication in the UK is worrisome and could result in individuals injecting products of unknown origin.
Some professionals said the demand for retatrutide could be linked to the rising price of approved weight loss treatments such as Mounjaro.
Legal Status and Implementation
Selling the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed drug that cannot be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.
Some content creators try to sidestep the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still violate pharmaceutical, marketing, and customer laws, potentially leading to penalties, prosecution or imprisonment.
Service Reaction and Content Elimination
Based on TikTok, the platform has taken down violative content and banned associated hashtags and search suggestions. The company said it was dedicated to keeping the service safe and investing in enhancing enforcement strategies.
Digital Trading Operations
Research also found communities with up to nine thousand participants selling retatrutide using Telegram's built-in search feature, which functions like a public directory. Typing “retatrutide” instantly displays groups with thousands of members, filled with images of weight loss, positive testimonials and detailed guides for mixing or injecting at residence.
Within minutes of joining one community, a seller shared contact information, where the majority of transactions take place. The vendor provided an instruction manual and guaranteed delivery within 48 hours. When questioned whether the substance was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. None inquired about weight, medical conditions or past usage.
Item Information and Costs
Within these communities, messages show dark colored packages with Royal Mail stickers, stating to include fresh supplies. One message read: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, mixed at residence with purified liquid, or pre-filled pens typically sold at 160 pounds for 20mg. When questioned how much time a injector should last, sellers give conflicting answers varying between a several days to “depends on your body”.
Service Oversight and Safety Actions
A spokesperson for Telegram stated it actively monitored harmful content on its service including content that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Cautions
“People are administering substances they can’t verify. Although the science behind this drug is sound, these digital versions may not include what they advertise,” stated a pharmacy expert, the director of pharmaceutical services at Chemist4U.
A medical professional of an online medical service linked the surge in demand to recent price rises for authorized slimming medications such as Mounjaro. “With costs rising, individuals are turning to online platforms. But counterfeit injections are highly dangerous. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she said.
Her staff has previously seen individuals harmed by self-injection from unconfirmed suppliers. “We understand the disappointment, but buying from messaging apps or WhatsApp is taking chances with your health,” said Wyllie. “These substances could be contaminated or incorrectly dosed.”
Manufacturer Position
A representative from Eli Lilly said the substance was in third stage clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Consequently at this point no one can market [it] for personal consumption,” they explained, noting that any product “falsely representing itself as a Lilly investigational product not yet approved … may subject patients to potentially significant medical dangers”.
